The U.S. travel technology firm Sabre may not ring an immediate bell, and perhaps you’ve not yet heard…
CFIF on Twitter CFIF on YouTube
On Sabre/Farelogix Merger, DOJ Mustn’t Undertake a Misguided Antitrust Boondoggle

The U.S. travel technology firm Sabre may not ring an immediate bell, and perhaps you’ve not yet heard of its proposed acquisition of Farelogix, but it looms as one of the most important antitrust cases to approach trial since AT&T/Time-Warner. The transaction’s most significant aspect is the way in which it offers a perfect illustration of overzealous bureaucratic antitrust enforcement, and the way that can delay and also punish American consumers. Specifically, the transaction enhances rather than inhibits market competition, and will benefit both travelers and the travel industry by accelerating innovation.  That’s in part because Sabre and Farelogix aren’t head-to-head market competitors, but rather complementary businesses.  While Sabre serves customers throughout the…[more]

January 13, 2020 • 03:53 pm

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's CourtroomLegal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts.
Home Press Room CFIF Urges Opposition to S. 977, Legislation to Import Foreign Price Controls
CFIF Urges Opposition to S. 977, Legislation to Import Foreign Price Controls Print
Thursday, April 04 2019

ALEXANDRIA, VA — In November of last year, the Center for Individual Freedom (“CFIF”) joined with 57 free-market organizations and individuals on a coalition letter opposing the importation of foreign price controls on prescription drugs, a proposal currently under consideration at the U.S. Department of Health and Human Services ("HHS").  In a coalition video released last week, several leading free-market voices, including CFIF, spoke out once again against the perils of imposing foreign price controls.

Unfortunately, recently introduced legislation by Senator Rick Scott (R-FL) entirely ignores that overwhelming opposition from conservatives and the free-market community and seeks to import foreign price controls into the U.S.  This legislation, known as the “Transparent Drug Pricing Act” (S.977), would fix U.S. drug prices to the lowest cost of the same drugs sold in five other countries: Canada, France, the United Kingdom, Japan and Germany.

It is CFIF's strong belief that importing socialist price controls in an effort to lower drug prices is the wrong approach and will reduce access to medicines, kill innovation and harm patients.  Therefore, CFIF urges Senators not to cosponsor or vote in favor of this harmful legislation.

###

 

 

Question of the Week   
Which one of the following was the first African-American soloist to appear at the Metropolitan Opera House in New York City?
More Questions
Quote of the Day   
 
"Federal prosecutors are scrutinizing whether former FBI Director James Comey leaked classified information about a possible Russian disinformation campaign to journalists, according to a bombshell New York Times report.The inquiry, which kicked off in recent months, appears to focus on information from documents that Dutch intelligence obtained from Russian computers and provided to the U.S. government…[more]
 
 
—Chuck Ross, Daily Caller
— Chuck Ross, Daily Caller
 
Liberty Poll   

Should witnesses be called for the Senate impeachment trial, which could take weeks or even months, or be restricted to the record and evidence already produced by the House?